Kearney's 2026 Executive M&A Report Forecasts Strengthened Chemical Deal Activity

Kearney’s 2026 Chemicals Executive M&A Report projects a notable strengthening of global chemical deal activity, building on momentum that gathered pace through 2025. The report captures a clear sentiment shift among industry leaders: consolidation is accelerating, but the character of transactions is changing. Rather than a wave of megamergers, executives foresee a landscape shaped by disciplined, small-to-mid-size acquisitions.

For chemical traders, procurement managers and importers, this shift carries immediate supply chain implications. When distributors, specialty formulators and regional compounders change hands, established sourcing channels can consolidate or redirect almost overnight. Understanding the deal thesis behind these transactions helps buying teams anticipate price, availability and service-level changes before they hit the purchase order.

2025 M&A Gains Built the Foundation

Global chemical deal volumes rose steadily in 2025, recovering from the cautious mood that dominated earlier years. Kearney’s data show that corporate balance sheets were healthier, private equity dry powder remained abundant and supply chain realignments pushed companies to acquire local capabilities rather than build them from scratch.

Dealmakers in 2025 focused on bolt-on acquisitions that strengthened specific technology platforms, regional distribution networks or additive portfolios. Many buyers prioritised targets with proven technical service teams and existing customer relationships over pure manufacturing assets. This approach reduced integration risk while delivering faster revenue synergies.

Small-to-Mid-Size Deals Set to Dominate

The 2026 outlook puts small-to-mid-size transactions at the centre of the M&A story. Kearney’s survey reveals that most chemical executives plan deals in the USD 50 million to USD 500 million range. These transactions let acquirers enter niche markets, pick up specialised formulation know-how or expand their geographic reach without over-leveraging.

For procurement teams, this trend means that even seemingly modest transactions can have a meaningful local impact. A mid-size distributor acquisition in Southeast Asia, for instance, can realign additive supply routes for compounders across multiple countries. A specialty resin manufacturer being absorbed by a larger platform may trigger changes in minimum order quantities, payment terms and technical support coverage.

Several structural forces make smaller deals attractive right now:

• Portfolio rebalancing: Large chemical groups continue to divest non-core units, creating a steady stream of carve-outs with strong customer books.

• Supply chain localisation: Global buyers increasingly want regional production and stock points, driving acquisitions of local formulators and distributors.

• Digital and service differentiation: Companies acquiring for technical service, e-commerce capability or application development labs find better value in targeted, bite-sized deals.

• Regulatory pressure on large mergers: Antitrust scrutiny in major jurisdictions makes small transactions faster to close and less risky.

Executive Sentiment and Confidence Signals

Kearney’s report highlights a notable uptick in executive confidence. A clear majority of respondents expect their own organisation to be an active buyer in 2026. That forward-looking sentiment draws on stabilising interest rates, greater visibility on energy and feedstock costs and the need to reposition supply chains around trade policy uncertainty.

Chemical leaders also pointed to the opportunity to acquire innovation. Targets with proprietary catalyst technologies, sustainable chemistry portfolios or advanced recycling capabilities command premium valuations. Buyers see these assets as long-term differentiators, not quick cost plays.

Regions and Segments Poised for Action

The report identifies several hotspots where deal activity will likely intensify. North America and Europe remain active for specialty chemicals and formulation science deals. Asia-Pacific draws attention for distribution and compounding acquisitions, particularly in India, Thailand and Vietnam.

Within chemical segments, specialty additives, adhesives, coatings and masterbatch businesses feature prominently in the pipeline. Buyers seek portfolios that serve high-growth end-markets like electric vehicle components, sustainable packaging and bio-based consumer goods. Feedstock and base chemical transactions continue, but the valuation multiples clearly favour differentiated, downstream assets.

What Deal Activity Means for Procurement Teams

Every acquisition has a procurement after-story. When a key supplier changes ownership, buying conditions rarely stay the same. The new parent may centralise purchasing contracts, shift credit terms, restructure sales territories or renegotiate principal agreements. Procurement teams that track M&A signals early can pivot before those changes disrupt production.

A tighter, more consolidated distribution landscape can also bring procurement benefits. Larger combined entities often hold deeper inventories, offer multi-site delivery and provide bundled commercial agreements. A compounder that previously juggled three separate additive distributors might cut administrative costs by consolidating spend under a single post-merger supplier.

However, the concentration of supplier power is a double-edged sword. When one distributor controls too much of a local market for a critical additive, buyers lose negotiating leverage. Keeping at least one qualified alternative supplier for every must-have chemical remains a non-negotiable discipline, even when a merger promises lower costs.

Risk Management in a Consolidating Market

The small-to-mid-size deal wave introduces specific risks that procurement leaders need to manage head-on. Integration delays can cause temporary service gaps. Key technical staff may leave during ownership transitions. Inventory rebalancing across merged warehouses can create short-term stock-outs on slow-moving SKUs.

Procurement teams can mitigate these risks with a few focused actions:

Map critical spend against known M&A targets and flag any supplier that falls into an announced deal.

Open early conversations with the new entity about contractual continuity, lead times and technical support.

Diversify safety stock across multiple approved grades or supplier sites for high-risk additives.

Monitor raw material qualification requirements, especially in regulated end-uses like food-contact or medical plastics, where a change in supplier ownership can trigger re-approval steps.

The Bottom Line for Chemical Buyers

Kearney’s 2026 report makes it clear that chemical M&A is entering a period of disciplined, widespread activity. Small-to-mid-size transactions will reshape distribution channels, redefine supplier relationships and alter regional competitive dynamics across multiple chemical segments. Buyers who wait for the dust to settle will find fewer options and less negotiating room.

Smart procurement teams will treat M&A intelligence as a core sourcing input in 2026. They will track deal announcements, reassess supplier concentration risks and engage early with the combined entities to lock in favourable terms. The deal pipeline is not just a headline for financial analysts. It is a direct signal of where supply, price and service are heading next.

Ready to source chemicals from verified global suppliers? Explore competitive offers on our platform today.